The synergistic regenerative and anti-inflammatory effects of Ponesimod and amniotic epithelial stem cells in the Cuprizone animal model of multiple sclerosis
Open Access
- 14 August 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
No abstract availableKeywords
Funding Information
- Shahid Beheshti University of Medical Sciences
This publication has 58 references indexed in Scilit:
- pH regulating mechanisms of astrocytes: A critical component in physiology and disease of the brainCell Calcium, 2024
- Neuroprotective effects of rutin against cuprizone-induced multiple sclerosis in miceInflammopharmacology, 2024
- The role and therapeutic potential of nuclear factor κB (NF-κB) in ischemic strokeBiomedicine & Pharmacotherapy, 2024
- Engineering chimeric autoantibody receptor T cells for targeted B cell depletion in multiple sclerosis model: An in-vitro studyHeliyon, 2023
- The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosisGlia, 2022
- Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile EffectsDrugs, 2020
- The differentiation effect of bone morphogenetic protein (BMP) on human amniotic epithelial stem cells to express ectodermal lineage markersCell and tissue research, 2020
- The Role of Astrocytes in CNS InflammationTrends in Immunology, 2020
- Behavioural and histological changes in cuprizone-fed miceBrain, Behavior, and Immunity, 2020
- Neuronal Regulation of Energy Homeostasis: Beyond the Hypothalamus and FeedingCell Metabolism, 2015